Snell & Wilmer represented Trawsfynydd Therapeutics, Inc. in the transaction, and Orrick, Herrington & Sutcliffe and Morgan, Lewis & Bockiu represented David Schulman.Trawsfynydd Therapeutics, Inc. (“Trawsfynydd”) announced…
Standard 1 Year Membership Required
You must be a Standard 1 Year member to access this content.
Already a member? Log in here
